ADC	Antibody drug conjugate.
AXL	Anexelekto.
BiTEs	Bispecific T cell engager molecules.
CAR-T	Chimeric antigen receptor T cells.
DHODH	Dihydroorotate dehydrogenase.
FLT3i	FLT3 inhibitors.
FLT3mut	FLT3 mutated AMLs.
GSK3	Glycogen synthase kinase 3.
HSC	Hematopoietic stem cell.
H3K9	Hystone 3 Lysin 9.
IGF2	Insulin-like growth factor 2.
LAIR-1	Leukocyte-associated immunoglobulin-like receptor-1.
LSC	Leukemic stem cell.
LSD1	lysine-specific demethylase 1.
MRD	Minimal residual disease.
NKGD2L	Natural killer group 2 member D ligand.
PDX	Patient-derived xenograft.
RR	Relapse refractory.
SD	Signaling domain.
UniCAR	Universal chimeric antigen receptor.